Reduced efficacy concerns GLP-1 receptor agonists are designed to work at specific doses to achieve optimal receptor activation (saturation) and to provide full therapeutic effect
Not Drinking Enough Water Hydration is one of the most commonly overlooked areas while using GLP-1 medications
In Saffrans case, that stress was the significant weight loss she experienced since being on Ozempic, Moustafa said
Importantly, such variability does not negate biological relevance, but rather underscores the challenge of translating dynamic, context-sensitive endocrine signals into static biomarkers
Phase 2 trials have shown impressive results, and a recently published phase 3 trial had even better findings
The following search algorithm was applied: ((GLP-1 receptor agonist OR glucagon-like peptide-1 receptor agonist OR GIP receptor agonist OR glucose-dependent insulinotropic polypeptide OR liraglutide OR semaglutide OR dulaglutide OR tirzepatide) AND (body composition OR fat mass OR muscle mass OR lean mass OR adiposity OR body fat OR sarcopenia)) AND (clinical trial OR study OR randomized controlled trial OR RCT OR intervention study)